Host-acting antibacterial compounds combat cytosolic bacteria.

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Rising prevalence of multidrug-resistant (MDR) bacterial infections poses a significant global health challenge.
• Traditional antibiotics are increasingly ineffective against MDR pathogens, necessitating novel therapeutic strategies.
• Host-acting antibacterial compounds (HACs) represent an emerging approach to combat intracellular bacterial infections.

Purpose of the Study:

• To review the interactions between host cells and facultative intracellular bacteria.
• To identify potential targets for the discovery and development of HACs.
• To summarize the mechanisms and activities of recently developed HACs against bacterial infections.

Main Methods:

• Literature review focusing on host-pathogen interactions.
• Analysis of existing data on HACs, their targets, and modes of action.
• Synthesis of information on pharmacological activities of HACs.

Main Results:

• HACs demonstrate potential in reducing or eliminating internalized bacteria.
• Specific host-bacterial interactions offer targets for HAC development.
• Various HACs exhibit diverse mechanisms against pathogenic bacteria.

Conclusions:

• HACs provide a promising alternative strategy for treating infections caused by cytosolic bacteria.
• This review highlights pathways for developing novel antibacterial agents targeting intracellular pathogens.
• Further research into HACs is crucial for addressing the threat of MDR infections.